NCT03383913View on ClinicalTrials.gov

HRV-B for Symptom Management in Sickle Cell Patients

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 22, 2018

Primary Completion Date

December 28, 2018

Study Completion Date

December 28, 2018

Conditions
Sickle Cell Disease
Interventions
BEHAVIORAL

Heart Rate Variability Biofeedback

Over a period of 4-6 weeks participants in the intervention arm will learn a series of breathing techniques to determine Heart Rate Variability's effects on physical function, anxiety, depression, fatigue, sleep disturbance, participation in social activities, pain interference and intensity.

Trial Locations (1)

29605

Center for Integrative Oncology and Survivorship, Greenville

All Listed Sponsors
collaborator

University of South Carolina

OTHER

lead

Prisma Health-Upstate

OTHER

NCT03383913 - HRV-B for Symptom Management in Sickle Cell Patients | Biotech Hunter | Biotech Hunter